Rheumatic Diseases  >>  toreforant (JNJ-38518168)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
toreforant (JNJ-38518168) / J&J
NCT01862224: A Synovial Biopsy Study of JNJ-38518168 in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Terminated
2
21
US, RoW
JNJ-38518168, Placebo, Methotrexate
Janssen Research & Development, LLC
Rheumatoid Arthritis
07/14
07/14

Download Options